Locally-produced medicines and devices

To help achieve UHC by 2030, PATH is supporting new markets and regulatory systems for local producers of essential medicines and medical devices.

Local production of essential medicines and medical devices improves access to quality health care and provides critical protection against health threats. PATH works with governments to develop policies and regulations that provide frameworks to expand health product manufacturing and support local manufacturers to meet international quality standards. Creating new markets for local producers is critical to the sustainability of local production—and for the achievement of UHC.